AZD8701
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD8701, covering 2024-11-05 to 2024-11-05. Get the full timeline:
Most recent: Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]